Your search for storm returned 1871 results

The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.

More skilled nursing providers are embracing Institutional Special Needs Plans by joining existing programs or creating their own as enrollment in other Medicare Advantage plans surpass half of all Medicare...

The CORS tool allows behavior to be anonymously reported and addressed by a trained peer, without involving nursing leadership or human resources unless necessary.

Nearly 40% of skilled nursing owners, top executives and administrators expect they will sell some or all of their nursing home holdings in the coming year, the McKnight’s 2023 Outlook survey reveals.

COVID hospitalizations approach last summer’s high, but flu and RSV cases waning … NC nursing home to pay $126K after storm-related staff shortages, two patient deaths … FDA decision on experimental...

The U.S. has opened more access to an influenza antiviral to help clinicians cope with rising demand during the worst flu season in a decade

As the nursing home sector tried to move out of COVID-19’s shadow in 2022, new challenges rushed in. It was a year filled with more, largely unwanted, attention from lawmakers and regulators, and legal...

Here is a look at 2022’s most popular blogs and most listened to podcasts from McKnight’s, as indicated by hundreds of thousands of reader clicks.

Nursing home news is clinical news: Top industry stories from 2022 … National Alzheimer’s plan supports research, COVID testing in assisted living … Diabetes drugs Trulicity and Mounjaro in short...

Nursing homes that are not already enrolled as full providers in the CDC’s COVID-19 Vaccination Program now can apply to provide shots directly to residents and staff.